EVOK - イヴォ―ク・ファ―マ (Evoke Pharma Inc.) イヴォ―ク・ファ―マ

 EVOKのチャート


 EVOKの企業情報

symbol EVOK
会社名 Evoke Pharma Inc (イヴォ―ク・ファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 イヴォーク・ファーマ(Evoke Pharma Inc.)は特殊製薬会社である。同社は主に胃腸(GI)の障害と疾患を治療する薬剤の開発に取り組む。同社は真性糖尿病を持つ女性の急性・再発糖尿病性胃不全麻痺に関連する症状の軽減向けのメトクロプラミド鼻腔用スプレーである「EVK-001」を開発している。同社の主要候補製品「EVK-001」は後期臨床試験にある。「EVK-001」は鼻腔内投与を通じてメトクロプラミドの全身的送達を提供するように設計された製剤である。胃不全麻痺は機械的閉塞がない場合の胃内容排出遅延という疾患である。胃不全麻痺は食品が正常より長い時間胃の中に残ることをもたらし、多様な症状を生じる。   イヴォ―ク・ファ―マは、米国の医薬品会社。主に、胃腸疾患の治療薬の研究開発に従事。中でも、糖尿病性胃不全麻痺の治療用メトクロプラミド鼻腔内投与システム「EVK-001」の商品化を目指し、同薬の臨床試験に焦点を当てている。本社は、カリフォルニア州ソラナ・ビ―チ。   Evoke is a specialty pharmaceutical company focused primarily on the commercialization and development of drugs to treat GI disorders and diseases. The Company developed GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.
本社所在地 420 Stevens Avenue Suite 370 Solana Beach CA 92075 USA
代表者氏名 Cam L. Garner カム・L・ガーナー
代表者役職名 Chairman and Co Founder
電話番号 +1 858-345-1494
設立年月日 39083
市場名 NASDAQ Small Cap
ipoyear 2013年
従業員数
url www.evokepharma.com
nasdaq_url https://www.nasdaq.com/symbol/evok
adr_tso
EBITDA EBITDA(百万ドル) -11.08459
終値(lastsale) 2.58
時価総額(marketcap) 43598553.12
時価総額 時価総額(百万ドル) 45.28842
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 38.75734
当期純利益 当期純利益(百万ドル) -9.83748
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Evoke Pharma Inc revenues was not reported. Net loss decreased 36% to $4.3M. Lower net loss reflects FV Adjustments of Financial Investments. increase from $1.8M (expense) to $436K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.48 to -$0.27.

 EVOKのテクニカル分析


 EVOKのニュース

   Trading - Evoke Pharma, Inc. Short Interest Update  2022/05/25 22:07:10 Business Mag
Evoke Pharma, Inc. was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 34,800 shares, a decrease…
   GeoVax, Entasis top healthcare gainers, while Nymox, Evoke Pharma lead losers'' pack  2022/05/23 14:01:40 Seeking Alpha
GeoVax Labs GOVX +39%. Entasis Therapeutics ETTX +21%. Nymox Pharmaceutical NYMX -67%. Evoke Pharma EVOK -21%.
   Evoke study shows lower risk of TD among patients treated with metoclopramide  2022/05/23 13:21:53 Seeking Alpha
Evoke Pharma (EVOK) announced on Monday that a real-world data analyses showed a lower risk of tardive dyskinesia among gastroparesis patients treated with metoclopramide compared…
   HIVE Blockchain Technologies, Molecular Data, Evoke Pharma among premarket losers'' pack  2022/05/23 12:18:34 Seeking Alpha
HIVE Blockchain Technologies (HIVE) -79%.Molecular Data MKD -27% on ADS ratio changeEvoke Pharma (EVOK) -22% after real-world data analysis reveals a lower risk of Tardive Dyskinesia…
   Patient Experience Survey Reported Positive Findings for GIMOTI  2022/05/18 12:30:00 Wallstreet:Online
Research Study Among Patients Demonstrated Favorable Acceptance and Utilization of GIMOTI SOLANA BEACH, Calif. and CHICAGO, May 18, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA, a leading provider of global commercial services to the life science industry, today announced positive
   Evoke Pharma to Report First Quarter 2022 Financial Results on May 10, 2022  2022/05/03 12:30:00 GlobeNewswire
SOLANA BEACH, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its first quarter 2022 financial results on Tuesday, May 10, 2022, after the market closes.
   Thinking about buying stock in Blue Apron, Luokung Technology, Evoke Pharma, IT Tech Packaging, or Spirit Airlines?  2022/05/02 14:50:00 Benzinga
NEW YORK , May 2, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APRN, LKCO, EVOK, ITP, and SAVE. … Full story available on Benzinga.com
   71 Biggest Movers From Yesterday  2022/04/27 08:27:24 Benzinga
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK ) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma''s Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults. Nutex Health, Inc. (NASDAQ: NUTX ) gained 73.8% to close at $7.68 on above-average volume despite no company-specific news. Cyngn Inc. (NASDAQ: CYN ) jumped 52.1% to close at $3.68 on above-average volume despite no company-specific news to justify the price action. Forge Global Holdings, Inc. (NYSE: FRGE ) gained 40.4% to close at $18.46 on above-average volume. GeoVax Labs, Inc. (NASDAQ: GOVX ) jumped 29.8% to settle at $1.11. The U.S. Patent and Trademark Office issued Patent No. 11,311,612 covering GeoVax Labs modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite. Jiuzi Holdings, Inc. (NASDAQ: JZXN ) gained 27.3% to close at $1.68 after the company announced it entered into an equity acquisition agreement to acquire an automobile sales serviceshop operator under top china automaker Geely Auto''s premium electronic vehicle brand Geometry.
   Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Protagonist Therapeutics Shares Plummet  2022/04/26 18:31:04 Benzinga
U.S. stocks remained lower toward the end of trading, with the Dow Jones tumbling more than 500 points on Tuesday. The Dow traded down 1.57% to 33,516.56 while the NASDAQ fell 2.72% to 12,650.53. The S&P also fell, dropping, 1.79% to 4,219.17. Also check this: Executives Buy Around $65M Of 3 Stocks Leading and Lagging Sectors Energy shares rose by 1.4% on Tuesday. Meanwhile, top gainers in the sector included Arch Resources, Inc. (NYSE: ARCH ), up 19% and PHX Minerals Inc. (NYSE: PHX ) up 8%. In trading on Tuesday, consumer discretionary shares dipped by 4.3%. Top Headline PepsiCo Inc (NASDAQ: PEP ) reported better-than-expected earnings for its first quarter on Tuesday. PepsiCo reported first-quarter FY22 sales growth of 9.3% year-on-year to $16.2 billion, beating the consensus of $15.53 billion. Adjusted EPS of $1.29 beat the analyst consensus of $1.23. PepsiCo continues to expect FY22 core constant currency EPS growth of 8%. The assumption implies FY22 core EPS of $6.63 (consensus $6.65), a 6% increase compared to 2021 core EPS of $6.26.
   FFIE, EVOK and ZY among mid-day movers  2022/04/26 17:11:22 Seeking Alpha
Gainers: Evoke Pharma (EVOK) +151%.Avadel Pharmaceuticals AVDL +26%.Arch Resources ARCH +21%.Magnachip Semiconductor MX +20%.TradeUP Global (TUGCU) +20%.Jiuzi Holdings (JZXN)…
   Todays Hot Stock Under Review: American Airlines Group Inc. (NASDAQ:AAL), Evoke Pharma, Inc. (NASDAQ:EVOK)  2022/02/21 02:54:53 Stock Equity
American Airlines Group Inc. (NASDAQ:AAL) with the stream of -1.92% also noticed, India Evoke Pharma, Inc. (NASDAQ:EVOK) encountered a rapid change of -2.52% in the last hour of Fridays trading The post Todays Hot Stock Under Review: American Airlines Group Inc. (NASDAQ:AAL), Evoke Pharma, Inc. (NASDAQ:EVOK) appeared first on Stocks Equity .
   Evoke Pharma, Eversana extend commercialization contract for Gimoti  2022/02/02 17:53:42 Seeking Alpha
Evoke Pharma <> and Eversana Life Science Services extended their agreement to continue collaborating on the commercialization and distribution of Gimoti (metoclopramide) nasal
   Evoke Pharma Inc Shares Close in on 52-Week Low - Market Mover  2022/01/18 06:05:46 Kwhen Finance
Evoke Pharma Inc (EVOK) shares closed today at 1.7% above its 52 week low of $0.50, giving the company a market cap of $16M. The stock is currently down 7.5% year-to-date, down 81.7% over the past 12 months, and down 78.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 38.0% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -390.2% The company's stock price performance over the past 12 months lags the peer average by -1187.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Evoke Pharma Inc Shares Approach 52-Week Low - Market Mover  2022/01/16 23:10:32 Kwhen Finance
Evoke Pharma Inc (EVOK) shares closed today at 1.7% above its 52 week low of $0.50, giving the company a market cap of $16M. The stock is currently down 7.5% year-to-date, down 81.7% over the past 12 months, and down 78.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 38.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -390.2% The company's stock price performance over the past 12 months lags the peer average by -1187.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Evoke Pharma Inc Shares Near 52-Week Low - Market Mover  2022/01/15 12:31:43 Kwhen Finance
Evoke Pharma Inc (EVOK) shares closed today at 1.7% above its 52 week low of $0.50, giving the company a market cap of $16M. The stock is currently down 7.5% year-to-date, down 82.5% over the past 12 months, and down 78.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 38.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.2% lower than its 5-day moving average, 10.1% lower than its 20-day moving average, and 47.3% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -458.4% The company's stock price performance over the past 12 months lags the peer average by -1795.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (医薬品 米国株 イヴォ―ク・ファ―マ EVOK Evoke Pharma Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)